183 related articles for article (PubMed ID: 26470730)
41. Foxo3 is required for the regulation of oxidative stress in erythropoiesis.
Marinkovic D; Zhang X; Yalcin S; Luciano JP; Brugnara C; Huber T; Ghaffari S
J Clin Invest; 2007 Aug; 117(8):2133-44. PubMed ID: 17671650
[TBL] [Abstract][Full Text] [Related]
42. Protein serine/threonine phosphatase-1 dephosphorylates p53 at Ser-15 and Ser-37 to modulate its transcriptional and apoptotic activities.
Li DW; Liu JP; Schmid PC; Schlosser R; Feng H; Liu WB; Yan Q; Gong L; Sun SM; Deng M; Liu Y
Oncogene; 2006 May; 25(21):3006-22. PubMed ID: 16501611
[TBL] [Abstract][Full Text] [Related]
43. Adenosine monophosphate activated protein kinase (AMPK), a mediator of estradiol-induced apoptosis in long-term estrogen deprived breast cancer cells.
Chen H; Wang JP; Santen RJ; Yue W
Apoptosis; 2015 Jun; 20(6):821-30. PubMed ID: 25721362
[TBL] [Abstract][Full Text] [Related]
44. Role of FOXO3 Activated by HIV-1 Tat in HIV-Associated Neurocognitive Disorder Neuronal Apoptosis.
Dong H; Ye X; Zhong L; Xu J; Qiu J; Wang J; Shao Y; Xing H
Front Neurosci; 2019; 13():44. PubMed ID: 30778283
[TBL] [Abstract][Full Text] [Related]
45. FOXO3 is differentially required for CD8
Wagle MV; Parish IA
Immunol Cell Biol; 2016 Oct; 94(9):895-899. PubMed ID: 27323690
[TBL] [Abstract][Full Text] [Related]
46. Tumor necrosis factor-alpha decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway.
Frost RA; Nystrom GJ; Lang CH
Endocrinology; 2003 May; 144(5):1770-9. PubMed ID: 12697682
[TBL] [Abstract][Full Text] [Related]
47. MST1 activation by curcumin mediates JNK activation, Foxo3a nuclear translocation and apoptosis in melanoma cells.
Yu T; Ji J; Guo YL
Biochem Biophys Res Commun; 2013 Nov; 441(1):53-8. PubMed ID: 24134840
[TBL] [Abstract][Full Text] [Related]
48. FOXO3 selectively amplifies enhancer activity to establish target gene regulation.
Eijkelenboom A; Mokry M; Smits LM; Nieuwenhuis EE; Burgering BM
Cell Rep; 2013 Dec; 5(6):1664-78. PubMed ID: 24360957
[TBL] [Abstract][Full Text] [Related]
49. Cellular function of chicken FOXO3 and its associations with chicken growth.
Chen B; Guo L; Chen X; El-Senousey HK; Ma M; Jebessa E; Nie Q
Poult Sci; 2019 Oct; 98(10):5109-5117. PubMed ID: 31265733
[TBL] [Abstract][Full Text] [Related]
50. Lineage-specific growth inhibition of NK cell lines by FOXO3 in association with Akt activation status.
Karube K; Tsuzuki S; Yoshida N; Arita K; Liu F; Kondo E; Ko YH; Ohshima K; Nakamura S; Kinoshita T; Seto M
Exp Hematol; 2012 Dec; 40(12):1005-1015.e6. PubMed ID: 22922206
[TBL] [Abstract][Full Text] [Related]
51. A novel function of FoxO transcription factors in thrombin-stimulated vascular smooth muscle cell proliferation.
Mahajan SG; Fender AC; Meyer-Kirchrath J; Kurt M; Barth M; Sagban TA; Fischer JW; Schrör K; Hohlfeld T; Rauch BH
Thromb Haemost; 2012 Jul; 108(1):148-58. PubMed ID: 22552808
[TBL] [Abstract][Full Text] [Related]
52. MiR-155 is upregulated in patients with active tuberculosis and inhibits apoptosis of monocytes by targeting FOXO3.
Huang J; Jiao J; Xu W; Zhao H; Zhang C; Shi Y; Xiao Z
Mol Med Rep; 2015 Nov; 12(5):7102-8. PubMed ID: 26324048
[TBL] [Abstract][Full Text] [Related]
53. Lipopolysaccharides-activated human astroglioma cells induce apoptotic death of T-lymphocytes via c-Jun N-terminal kinases-dependent up-regulation of TRAIL.
Kwon D; Cheong JH; Lee JC; Kwon JH; Kim WK
Neurosci Res; 2006 Apr; 54(4):338-43. PubMed ID: 16442178
[TBL] [Abstract][Full Text] [Related]
54. Ionizing radiation utilizes c-Jun N-terminal kinase for amplification of mitochondrial apoptotic cell death in human cervical cancer cells.
Kim MJ; Lee KH; Lee SJ
FEBS J; 2008 May; 275(9):2096-108. PubMed ID: 18373696
[TBL] [Abstract][Full Text] [Related]
55. Mitoxantrone induces apoptosis in osteosarcoma cells through regulation of the Akt/FOXO3 pathway.
Park SH; Lee J; Kang MA; Jang KY; Kim JR
Oncol Lett; 2018 Jun; 15(6):9687-9696. PubMed ID: 29928344
[TBL] [Abstract][Full Text] [Related]
56. Investigation of FoxO3 dynamics during erythroblast development in β-thalassemia major.
Thanuthanakhun N; Nuntakarn L; Sampattavanich S; Anurathapan U; Phuphanitcharoenkun S; Pornpaiboonstid S; Borwornpinyo S; Hongeng S
PLoS One; 2017; 12(11):e0187610. PubMed ID: 29099866
[TBL] [Abstract][Full Text] [Related]
57. Metformin Alleviates Radiation-Induced Skin Fibrosis via the Downregulation of FOXO3.
Kim JM; Yoo H; Kim JY; Oh SH; Kang JW; Yoo BR; Han SY; Kim CS; Choi WH; Lee EJ; Byeon HJ; Lee WJ; Lee YS; Cho J
Cell Physiol Biochem; 2018; 48(3):959-970. PubMed ID: 30036874
[TBL] [Abstract][Full Text] [Related]
58. The forkhead box O3 (FOXO3): a key player in the regulation of ischemia and reperfusion injury.
Omorou M; Huang Y; Gao M; Mu C; Xu W; Han Y; Xu H
Cell Mol Life Sci; 2023 Mar; 80(4):102. PubMed ID: 36939886
[TBL] [Abstract][Full Text] [Related]
59. Repaglinide Silences the FOXO3/Lumican Axis and Represses the Associated Metastatic Potential of Neuronal Cancer Cells.
Salcher S; Spoden G; Huber JM; Golderer G; Lindner H; Ausserlechner MJ; Kiechl-Kohlendorfer U; Geiger K; Obexer P
Cells; 2019 Dec; 9(1):. PubMed ID: 31861249
[TBL] [Abstract][Full Text] [Related]
60. A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma.
Salcher S; Spoden G; Hagenbuchner J; Führer S; Kaserer T; Tollinger M; Huber-Cantonati P; Gruber T; Schuster D; Gust R; Zwierzina H; Müller T; Kiechl-Kohlendorfer U; Ausserlechner MJ; Obexer P
Oncogene; 2020 Jan; 39(5):1080-1097. PubMed ID: 31591479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
